SGLT2 Inhibitors Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients
Conditions:   SGLT2 INHIBITORS;   Lupus Nephritis;   BMD Interventions:   Drug: Dapagliflozin tablet;   Drug: placebo Sponsor:   Mansoura University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials

SGLT2 Inhibitor for Severe Tricuspid Regurgitation
Condition:   Tricuspid Regurgitation Intervention:   Drug: Dapagliflozin Propanediol Hydrate 12.3 mg Sponsor:   Samsung Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2023 Category: Research Source Type: clinical trials